Related Experiment Videos
Phenylethanolamine N-methyltransferase gene expression. Sp1 and MAZ potential for tissue-specific expression
1Department of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California 94305-5485, USA.
The Journal of Biological Chemistry
|March 20, 1999
Summary
Sp1 transcription factor drives Phenylethanolamine N-methyltransferase (PNMT) gene expression in Neuro2A cells. Competition between Sp1 and MAZ transcription factors provides tissue-specific control of PNMT gene expression.
Area of Science:
- Molecular Biology
- Gene Regulation
- Neuroscience
Background:
- Phenylethanolamine N-methyltransferase (PNMT) is crucial for catecholamine synthesis.
- Understanding PNMT gene regulation is key to its tissue-specific expression.
Purpose of the Study:
- To investigate the molecular mechanisms controlling PNMT gene expression in Neuro2A cells.
- To identify transcription factors involved in PNMT promoter activity.
Main Methods:
- Transfection of PNMT promoter-luciferase constructs into various cell lines.
- DNase I footprinting and gel mobility shift assays.
- Site-directed mutagenesis and Southwestern analysis.
Main Results:
- Neuro2A cells exhibited the highest basal luciferase activity from PNMT promoter constructs.
- Sp1 (Specificity Protein 1) was identified as a key transcription factor mediating PNMT expression in Neuro2A cells.
- MAZ (MYC Associated zinc finger protein) was found to compete with Sp1, regulating PNMT promoter activity.
Conclusions:
- Sp1 plays a significant role in the tissue-specific expression of the PNMT gene.
- The interplay between Sp1 and MAZ provides an additional layer of tissue-specific control for PNMT gene regulation.